prof. dr. Piet Ost
Show
Sort by
-
Exploration of the urinary proteome in the search for new biomarkers for prostate cancer : a promising role for extracellular vesicles
-
Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial
-
Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma
-
Oligometastatic prostate cancer : the game is afoot
-
Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer : not ready for prime time
-
Understanding physical activity behavior in patients with bladder cancer before and after radical cystectomy : a qualitative interview study
-
Abiraterone and spironolactone in prostate cancer : a combination to avoid
-
Current insights in the management of high-risk prostate cancer : still more questions than answers
-
Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer
-
Pelvic lymph node dissection in prostate cancer staging : evaluation of morbidity and oncological outcomes